.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Chinese Patent Office
Covington
Dow
Chubb
McKesson
Baxter
Farmers Insurance
Julphar
Teva

Generated: December 12, 2017

DrugPatentWatch Database Preview

Clonazepam - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for clonazepam and what is the scope of clonazepam patent protection?

Clonazepam
is the generic ingredient in three branded drugs marketed by Barr, Par Pharm, Sun Pharm Inds Inc, Roche, Accord Hlthcare, Actavis Elizabeth, Apotex Inc, Mylan, Mylan Pharms Inc, Prinston Inc, Sandoz, Teva, and Watson Labs, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for clonazepam. Forty-eight suppliers are listed for this compound.

Pharmacology for clonazepam

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine

Medical Subject Heading (MeSH) Categories for clonazepam

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
TevaCLONAZEPAMclonazepamTABLET;ORAL074920-002Aug 4, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmCLONAZEPAMclonazepamTABLET, ORALLY DISINTEGRATING;ORAL077171-001Aug 3, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Accord HlthcareCLONAZEPAMclonazepamTABLET;ORAL077147-003May 2, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds IncCLONAZEPAMclonazepamTABLET;ORAL075423-002Apr 27, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsCLONAZEPAMclonazepamTABLET;ORAL074964-002Dec 30, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Pharms IncCLONAZEPAMclonazepamTABLET;ORAL074940-002Oct 30, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BarrCLONAZEPAMclonazepamTABLET, ORALLY DISINTEGRATING;ORAL077194-002Aug 10, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozCLONAZEPAMclonazepamTABLET;ORAL074979-003Aug 29, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Apotex IncCLONAZEPAMclonazepamTABLET;ORAL075468-002Oct 6, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaCLONAZEPAMclonazepamTABLET;ORAL074569-001Sep 10, 1996ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: clonazepam

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
RocheKLONOPINclonazepamTABLET;ORAL017533-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
RocheKLONOPIN RAPIDLY DISINTEGRATINGclonazepamTABLET, ORALLY DISINTEGRATING;ORAL020813-003Dec 23, 1997► Subscribe► Subscribe
RocheKLONOPIN RAPIDLY DISINTEGRATINGclonazepamTABLET, ORALLY DISINTEGRATING;ORAL020813-005Dec 23, 1997► Subscribe► Subscribe
RocheKLONOPIN RAPIDLY DISINTEGRATINGclonazepamTABLET, ORALLY DISINTEGRATING;ORAL020813-004Dec 23, 1997► Subscribe► Subscribe
RocheKLONOPIN RAPIDLY DISINTEGRATINGclonazepamTABLET, ORALLY DISINTEGRATING;ORAL020813-001Dec 23, 1997► Subscribe► Subscribe
RocheKLONOPIN RAPIDLY DISINTEGRATINGclonazepamTABLET, ORALLY DISINTEGRATING;ORAL020813-003Dec 23, 1997► Subscribe► Subscribe
RocheKLONOPINclonazepamTABLET;ORAL017533-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
RocheKLONOPIN RAPIDLY DISINTEGRATINGclonazepamTABLET, ORALLY DISINTEGRATING;ORAL020813-005Dec 23, 1997► Subscribe► Subscribe
RocheKLONOPIN RAPIDLY DISINTEGRATINGclonazepamTABLET, ORALLY DISINTEGRATING;ORAL020813-003Dec 23, 1997► Subscribe► Subscribe
RocheKLONOPIN RAPIDLY DISINTEGRATINGclonazepamTABLET, ORALLY DISINTEGRATING;ORAL020813-002Dec 23, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Covington
Boehringer Ingelheim
US Department of Justice
QuintilesIMS
Novartis
Farmers Insurance
Deloitte
Citi
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot